These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37781369)

  • 1. Case Report: ASCENIV use in three young children with immune abnormalities and acute respiratory failure secondary to RSV infection.
    Bindernagel C; Sotoudeh S; Nguyen M; Wetzstein G; Sriaroon P; Walter J
    Front Immunol; 2023; 14():1154448. PubMed ID: 37781369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.
    Falsey AR; Koval C; DeVincenzo JP; Walsh EE
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Immunoglobulin treatment for respiratory syncytial virus infection.
    Fuller HL; Del Mar CB
    Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD004883. PubMed ID: 20824840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus immune globulin: decisions and costs.
    Barton LL; Grant KL; Lemen RJ
    Pediatr Pulmonol; 2001 Jul; 32(1):20-8. PubMed ID: 11416872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin treatment for respiratory syncytial virus infection.
    Fuller H; Del Mar C
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004883. PubMed ID: 17054220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
    Wasserman RL; Lumry W; Harris J; Levy R; Stein M; Forbes L; Cunningham-Rundles C; Melamed I; Kobayashi AL; Du W; Kobayashi R
    J Clin Immunol; 2016 Aug; 36(6):590-9. PubMed ID: 27324887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus immune globulin intravenous.
    Wandstrat TL
    Ann Pharmacother; 1997 Jan; 31(1):83-8. PubMed ID: 8997472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of respiratory syncytial virus immune globulin in 1996-1997: a local controlled comparison.
    Redding GJ; Braun S; Mayock D
    Arch Pediatr Adolesc Med; 1999 May; 153(5):503-7. PubMed ID: 10323631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: part I.
    Sandritter TL; Kraus DM
    J Pediatr Health Care; 1997; 11(6):284-91; quiz 292-3. PubMed ID: 9423415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
    Marcelin JR; Wilson JW; Razonable RR;
    Transpl Infect Dis; 2014 Apr; 16(2):242-50. PubMed ID: 24621016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
    Groothuis JR; Hoopes JM; Hemming VG
    Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group.
    Simoes EA; Sondheimer HM; Top FH; Meissner HC; Welliver RC; Kramer AA; Groothuis JR
    J Pediatr; 1998 Oct; 133(4):492-9. PubMed ID: 9787686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
    Wasserman RL; Greener BN; Mond J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1107-1119. PubMed ID: 29035131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children.
    Chu HY; Chin J; Pollard J; Zerr DM; Englund JA
    Influenza Other Respir Viruses; 2016 May; 10(3):205-10. PubMed ID: 26859306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review.
    Hon KL; Leung AKC; Wong AHC; Dudi A; Leung KKY
    Curr Pediatr Rev; 2023; 19(2):139-149. PubMed ID: 35950255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.
    Jacque E; Chottin C; Laubreton D; Nogre M; Ferret C; de Marcos S; Baptista L; Drajac C; Mondon P; De Romeuf C; Rameix-Welti MA; Eléouët JF; Chtourou S; Riffault S; Perret G; Descamps D
    Front Immunol; 2021; 12():683902. PubMed ID: 34163482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of respiratory syncytial virus infections among children with sickle cell disease.
    Rostad CA; Maillis AN; Lai K; Bakshi N; Jerris RC; Lane PA; Yee ME; Yildirim I
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28759. PubMed ID: 33034160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.
    Rodriguez WJ; Gruber WC; Groothuis JR; Simoes EA; Rosas AJ; Lepow M; Kramer A; Hemming V
    Pediatrics; 1997 Dec; 100(6):937-42. PubMed ID: 9374560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.